Home / Companies / Altimmune, Inc. / 26 Sep 2024
Altimmune, Inc.: meeting of 26 Sep 2024
Votes reported on Form N-PX, item by item
220 Form N-PX filers reported votes at the Altimmune, Inc. meeting of 26 Sep 2024. Their records fall into 4 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
8 nominees; 89.3% of reported votes for; 28 filers withheld from or voted against at least one nominee.
1,105 vote records from 72 filers. 0 of the 71 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
310 vote records from 218 filers. 145 of the 210 filers that marked the item either way voted against management. 8 filers reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
139 vote records from 72 filers. 1 of the 71 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
137 vote records from 70 filers. 55 of the 69 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
How the largest families voted
| Family | 1. Directors | 2. Say-on-pay | 3. Auditor |
|---|---|---|---|
| Vanguard | For | For | For |
| BlackRock and iShares | For | Against * | For |
| Fidelity | For | Against * | For |
| Dimensional | Split or no vote | Against * | For |
| State Street and SPDR | For | For | For |
| American Century | For | Against * | For |
| Invesco | No report | Against * | No report |
| Equitable | For | Against * | For |
| Charles Schwab | For | Against * | For |
| Nuveen and TIAA | For | Against * | For |
| ProShares and ProFunds | For | Against * | For |
| John Hancock and Manulife | For | Against * | For |
| Morgan Stanley, Eaton Vance and Calvert | For | For | For |
| J.P. Morgan | No report | For | No report |
| Goldman Sachs | For | Against * | For |
| PGIM and Prudential | No report | Against * | No report |
| Northern Trust and FlexShares | For | For | For |
| SEI | For | Against * | For |
| T. Rowe Price | For | Against * | For |
| Lincoln Financial | For | For | For |
| Voya | For | For | For |
| Russell Investments | No report | Against * | No report |
| Nationwide | For | Against * | For |
| Victory Capital | For | Against * | For |
| Brighthouse Funds | For | Against * | For |
| Guggenheim and Rydex | For | Against * | For |
| Columbia Threadneedle | For | For | For |
| BNY Mellon | No report | Against * | No report |
| Principal | No report | Against * | No report |
| Pacific Life funds | For | Against * | For |
| Global X | For | Against * | For |
| AllianceBernstein | No report | Against * | No report |
| DWS | For | Against * | For |
| Macquarie and Delaware Funds | For | Against * | For |
| Janus Henderson | No report | Against * | No report |
| Neuberger Berman | No report | Against * | No report |
| Natixis and Loomis Sayles | No report | Against * | No report |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Altimmune, Inc. meeting?
220 Form N-PX filers reported votes at the meeting of 26 Sep 2024. On say-on-pay, 145 of 210 voted against management (69.0%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Altimmune, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Altimmune, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Altimmune, Inc. with a meeting date within three days of 26 Sep 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.